![]() Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. | ![]() Helsinn Group Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer. | ![]() Debiopharm Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections. | ||
Founding Date | Founding Date 1968 | Founding Date 2013 | Founding Date 1976 | Founding Date 1979 |
Type | Type Subsidiary | Type Subsidiary | Type Private | Type Private |
Tags | ||||
Locations | Locations Gropello Cairoli, IT HQ | Locations San Diego, US HQ | Locations Pazzallo, CH HQ Shanghai, CN Monaco, MC Biasca, CH Woodbridge Township, US | Locations Lausanne, CH HQ Oss, NL |
Employees | Employees 281 | Employees 474% decrease | Employees 3731% decrease | Employees 4771% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) €143.2m (Y, 2025) | Revenue (est.) $30.8m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income €38.6m (Y, 2025) | Net income ($236.6m) (FY, 2021) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 144.4m | Total funding raised N/A | Total funding raised $ 2.1m |

Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View company
Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer.
View company
Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections.
View company